Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1988 Nov;78(11):1417–1421. doi: 10.2105/ajph.78.11.1417

A cost-effectiveness analysis of exercise as a health promotion activity.

E I Hatziandreu 1, J P Koplan 1, M C Weinstein 1, C J Caspersen 1, K E Warner 1
PMCID: PMC1350231  PMID: 3140681

Abstract

We used cost-effectiveness analysis to estimate the health and economic implications of exercise in preventing coronary heart disease (CHD). We assumed that nonexercisers have a relative risk of 2.0 for a CHD event. Two hypothetical cohorts (one with exercise and the other without exercise) of 1,000 35-year-old men were followed for 30 years to observe differences in the number of CHD events, life expectancy, and quality-adjusted life expectancy. We used jogging as an example to calculate cost, injury rates, adherence, and the value of time spent. Both direct and indirect costs associated with exercise, injury, and treating CHD were considered. We estimate that exercising regularly results in 78.1 fewer CHD events and 1,138.3 Quality Adjusted Life Years (QALYs) gained over the 30-year study period. Under our base case assumptions, which include indirect costs such as time spent in exercise, exercise does not produce economic savings. However, the cost per QALY gained of $11,313 is favorable when compared with other preventive or therapeutic interventions for CHD. The value of time spent is a crucial factor, influencing whether exercise is a cost-saving activity. In an alternative model, where all members of the cohort exercise for one year, and then only those who like it or are neutral continue, exercise produces net economic savings as well as reducing morbidity.

Full text

PDF
1417

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Donahue R. P., Abbott R. D., Reed D. M., Yano K. Physical activity and coronary heart disease in middle-aged and elderly men: the Honolulu Heart Program. Am J Public Health. 1988 Jun;78(6):683–685. doi: 10.2105/ajph.78.6.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doubilet P., Weinstein M. C., McNeil B. J. Use and misuse of the term "cost effective" in medicine. N Engl J Med. 1986 Jan 23;314(4):253–256. doi: 10.1056/NEJM198601233140421. [DOI] [PubMed] [Google Scholar]
  3. Eddy D. M. The economics of cancer prevention and detection: getting more for less. Cancer. 1981 Mar 1;47(5 Suppl):1200–1209. doi: 10.1002/1097-0142(19810301)47:5+<1200::aid-cncr2820471325>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  4. Herzlinger R. E., Calkins D. How companies tackle health care costs: Part III. Harv Bus Rev. 1986 Jan-Feb;64(1):70–80. [PubMed] [Google Scholar]
  5. Koplan J. P., Axnick N. W. Benefits, risks and costs of viral vaccines. Prog Med Virol. 1982;28:180–191. [PubMed] [Google Scholar]
  6. Koplan J. P., Powell K. E., Sikes R. K., Shirley R. W., Campbell C. C. An epidemiologic study of the benefits and risks of running. JAMA. 1982 Dec 17;248(23):3118–3121. [PubMed] [Google Scholar]
  7. Mason J. O., Powell K. E. Physical activity, behavioral epidemiology, and public health. Public Health Rep. 1985 Mar-Apr;100(2):113–115. [PMC free article] [PubMed] [Google Scholar]
  8. Oster G., Epstein A. M. Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol. Am J Public Health. 1986 Jun;76(6):647–656. doi: 10.2105/ajph.76.6.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Paffenbarger R. S., Jr, Hyde R. T., Wing A. L., Hsieh C. C. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986 Mar 6;314(10):605–613. doi: 10.1056/NEJM198603063141003. [DOI] [PubMed] [Google Scholar]
  10. Paffenbarger R. S., Jr, Hyde R. T., Wing A. L., Steinmetz C. H. A natural history of athleticism and cardiovascular health. JAMA. 1984 Jul 27;252(4):491–495. [PubMed] [Google Scholar]
  11. Physical activity and longevity of college alumni. N Engl J Med. 1986 Aug 7;315(6):399–401. doi: 10.1056/NEJM198608073150618. [DOI] [PubMed] [Google Scholar]
  12. Powell K. E., Thompson P. D., Caspersen C. J., Kendrick J. S. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health. 1987;8:253–287. doi: 10.1146/annurev.pu.08.050187.001345. [DOI] [PubMed] [Google Scholar]
  13. Salonen J. T., Puska P., Tuomilehto J. Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. Am J Epidemiol. 1982 Apr;115(4):526–537. doi: 10.1093/oxfordjournals.aje.a113334. [DOI] [PubMed] [Google Scholar]
  14. Weinstein M. C., Stason W. B. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health. 1985;6:41–63. doi: 10.1146/annurev.pu.06.050185.000353. [DOI] [PubMed] [Google Scholar]
  15. Willems J. S., Sanders C. R. Cost-effectiveness and cost-benefit analyses of vaccines. J Infect Dis. 1981 Nov;144(5):486–493. doi: 10.1093/infdis/144.5.486. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES